BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 28008934)

  • 41. Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure.
    Tokheim C; Bhattacharya R; Niknafs N; Gygax DM; Kim R; Ryan M; Masica DL; Karchin R
    Cancer Res; 2016 Jul; 76(13):3719-31. PubMed ID: 27197156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types.
    Wang C; Gu Y; Zhang K; Xie K; Zhu M; Dai N; Jiang Y; Guo X; Liu M; Dai J; Wu L; Jin G; Ma H; Jiang T; Yin R; Xia Y; Liu L; Wang S; Shen B; Huo R; Wang Q; Xu L; Yang L; Huang X; Shen H; Sha J; Hu Z
    Nat Commun; 2016 Jan; 7():10499. PubMed ID: 26813108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer.
    Koschmann C; Nunez FJ; Mendez F; Brosnan-Cashman JA; Meeker AK; Lowenstein PR; Castro MG
    Cancer Res; 2017 Jan; 77(2):227-233. PubMed ID: 28062403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concordance of copy number loss and down-regulation of tumor suppressor genes: a pan-cancer study.
    Zhao M; Zhao Z
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):532. PubMed ID: 27556634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Many accurate small-discriminatory feature subsets exist in microarray transcript data: biomarker discovery.
    Grate LR
    BMC Bioinformatics; 2005 Apr; 6():97. PubMed ID: 15826317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discovering potential driver genes through an integrated model of somatic mutation profiles and gene functional information.
    Xi J; Wang M; Li A
    Mol Biosyst; 2017 Sep; 13(10):2135-2144. PubMed ID: 28825429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Paediatric cancer: Pan-cancer genomic analyses uncover molecular drivers.
    Killock D
    Nat Rev Clin Oncol; 2018 May; 15(5):263. PubMed ID: 29557392
    [No Abstract]   [Full Text] [Related]  

  • 48. Tumour Suppressors: Following the clues of cancer-resistant tissues.
    Seton-Rogers S
    Nat Rev Cancer; 2017 Apr; 17(5):269. PubMed ID: 28436471
    [No Abstract]   [Full Text] [Related]  

  • 49. [COMPILING AND USE OF BIBLIOGRAPHIES].
    LEVERINGTON J; SORIANO H; PEREZ M
    Rev Chil Pediatr; 1963 Nov; 34():877-81. PubMed ID: 14128149
    [No Abstract]   [Full Text] [Related]  

  • 50. An ensemble-based deep learning model for detection of mutation causing cutaneous melanoma.
    Ali Shah A; Shaker ASA; Jabbar S; Abbas Q; Al-Balawi TS; Celebi ME
    Sci Rep; 2023 Dec; 13(1):22251. PubMed ID: 38097641
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel Therapeutic Options for Small Cell Lung Cancer.
    Canova S; Trevisan B; Abbate MI; Colonese F; Sala L; Baggi A; Bianchi SP; D'Agostino A; Cortinovis DL
    Curr Oncol Rep; 2023 Nov; 25(11):1277-1294. PubMed ID: 37870696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumour Genetic Heterogeneity in Relation to Oral Squamous Cell Carcinoma and Anti-Cancer Treatment.
    Feller G; Khammissa RAG; Ballyram R; Beetge MM; Lemmer J; Feller L
    Int J Environ Res Public Health; 2023 Jan; 20(3):. PubMed ID: 36767758
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of deep learning techniques for identification of sarcoma-causing carcinogenic mutations.
    Shah AA; Alturise F; Alkhalifah T; Khan YD
    Digit Health; 2022; 8():20552076221133703. PubMed ID: 36312852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma.
    Ma Y; Qiu C; Wang B; Zhang X; Wang X; Aguilera RJ; Zhang JY
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of a Five-Gene Panel to Assess Prognosis for Gastric Cancer.
    Li S; Mao Q; Zhang Z; Wang Y; Chen D; Chen Z; Lu J
    Biomed Res Int; 2022; 2022():5593619. PubMed ID: 35187167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Performance Assessment of the Network Reconstruction Approaches on Various Interactomes.
    Arici MK; Tuncbag N
    Front Mol Biosci; 2021; 8():666705. PubMed ID: 34676243
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Current cancer driver variant predictors learn to recognize driver genes instead of functional variants.
    Raimondi D; Passemiers A; Fariselli P; Moreau Y
    BMC Biol; 2021 Jan; 19(1):3. PubMed ID: 33441128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. DORGE: Discovery of Oncogenes and tumoR suppressor genes using Genetic and Epigenetic features.
    Lyu J; Li JJ; Su J; Peng F; Chen YE; Ge X; Li W
    Sci Adv; 2020 Nov; 6(46):. PubMed ID: 33177077
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Directional association test reveals high-quality putative cancer driver biomarkers including noncoding RNAs.
    Zhong H; Song M
    BMC Med Genomics; 2019 Dec; 12(Suppl 7):129. PubMed ID: 31888644
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer driver genes: a guilty by resemblance doctrine.
    Ramsahai E; Tripathi V; John M
    PeerJ; 2019; 7():e6979. PubMed ID: 31275738
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.